VANGUARD GROUP INC 13D and 13G filings for Eagle Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 5:04 pm Sale | 2023-12-29 | 13G | EAGLE PHARMACEUTICALS INC EGRX | VANGUARD GROUP INC | 638,124 4.910% | -125,683 (-16.45%) | Filing |
| 2023-02-09 11:16 am Purchase | 2022-12-30 | 13G | EAGLE PHARMACEUTICALS INC EGRX | VANGUARD GROUP INC | 763,807 5.870% | 3,339 (+0.44%) | Filing |
| 2022-02-09 3:43 pm Sale | 2021-12-31 | 13G | EAGLE PHARMACEUTICALS INC EGRX | VANGUARD GROUP INC | 760,468 5.890% | -4,467 (-0.58%) | Filing |